ZIM Laboratories Limited (ZIMLAB.BO)
INR 113.15
(0.85%)
INR 113.15
(0.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.26 Billion INR | -34.8% |
| 2022 | 1.94 Billion INR | 14.65% |
| 2021 | 1.69 Billion INR | 25.31% |
| 2020 | 1.35 Billion INR | 15.81% |
| 2019 | 1.16 Billion INR | -29.79% |
| 2018 | 1.66 Billion INR | 32.36% |
| 2017 | 1.25 Billion INR | 14.94% |
| 2016 | 1.09 Billion INR | 3.31% |
| 2015 | 1.05 Billion INR | 34.0% |
| 2014 | 789.78 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 261.41 Million INR | -39.28% |
| 2023 Q2 | 459.06 Million INR | 26.36% |
| 2023 FY | 1.26 Billion INR | -34.8% |
| 2023 Q1 | 363.28 Million INR | -28.02% |
| 2023 Q3 | 520.76 Million INR | 13.44% |
| 2023 Q4 | 430.55 Million INR | -17.32% |
| 2022 Q4 | 504.72 Million INR | 1.86% |
| 2022 Q1 | 470.16 Million INR | -8.37% |
| 2022 Q2 | 472.74 Million INR | 0.55% |
| 2022 FY | 1.94 Billion INR | 14.65% |
| 2022 Q3 | 495.53 Million INR | 4.82% |
| 2021 Q4 | 513.12 Million INR | 14.27% |
| 2021 FY | 1.69 Billion INR | 25.31% |
| 2021 Q1 | 313.26 Million INR | 33.63% |
| 2021 Q3 | 449.02 Million INR | 7.22% |
| 2021 Q2 | 418.78 Million INR | 33.68% |
| 2020 Q2 | 382.13 Million INR | 10.33% |
| 2020 Q3 | 389.65 Million INR | 1.97% |
| 2020 FY | 1.35 Billion INR | 15.81% |
| 2020 Q4 | 234.43 Million INR | -39.84% |
| 2020 Q1 | 346.34 Million INR | 110.62% |
| 2019 Q1 | 301.57 Million INR | -19.85% |
| 2019 Q2 | 331.79 Million INR | 10.02% |
| 2019 FY | 1.16 Billion INR | -29.79% |
| 2019 Q4 | 164.44 Million INR | -55.57% |
| 2019 Q3 | 370.13 Million INR | 11.55% |
| 2018 Q4 | 376.26 Million INR | -26.05% |
| 2018 Q2 | 421.84 Million INR | 18.31% |
| 2018 Q1 | 356.55 Million INR | 36.98% |
| 2018 FY | 1.66 Billion INR | 32.36% |
| 2018 Q3 | 508.78 Million INR | 20.61% |
| 2017 Q4 | 260.3 Million INR | -30.15% |
| 2017 Q3 | 372.67 Million INR | 12.78% |
| 2017 Q1 | 294.18 Million INR | 0.0% |
| 2017 Q2 | 330.43 Million INR | 12.32% |
| 2017 FY | 1.25 Billion INR | 14.94% |
| 2016 FY | 1.09 Billion INR | 3.31% |
| 2015 FY | 1.05 Billion INR | 34.0% |
| 2014 FY | 789.78 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 93.986% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | 18.608% |
| Sigachi Industries Limited | 2 Billion INR | 36.728% |
| Bal Pharma Limited | 770.19 Million INR | -64.489% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 79.548% |
| Medico Remedies Limited | 262.14 Million INR | -383.279% |
| Lasa Supergenerics Limited | 121.02 Million INR | -946.755% |
| Venus Remedies Limited | 2.18 Billion INR | 41.955% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 310.305% |
| Alpa Laboratories Limited | 188.89 Million INR | -570.683% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 57.373% |
| Shilpa Medicare Limited | 3.54 Billion INR | 64.281% |
| Aarti Drugs Limited | 8.31 Billion INR | 84.766% |
| Lupin Limited | 123.71 Billion INR | 98.976% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 99.181% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.988% |
| Windlas Biotech Limited | 1.33 Billion INR | 5.371% |
| Suven Life Sciences Limited | -200.79 Million INR | 730.929% |
| Eris Lifesciences Limited | 10.42 Billion INR | 87.85% |
| Valiant Laboratories Limited | -60.66 Million INR | 2188.367% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 94.419% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -47.107% |
| Ipca Laboratories Limited | 29.8 Billion INR | 95.75% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 65.718% |
| Achyut Healthcare Limited | 4.86 Million INR | -25962.271% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.51% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 13.923% |
| RPG Life Sciences Limited | 2.48 Billion INR | 48.978% |
| Mankind Pharma Limited | 44.52 Billion INR | 97.154% |
| Laurus Labs Limited | 24.62 Billion INR | 94.854% |
| Piramal Pharma Limited | 24.47 Billion INR | 94.823% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -34.432% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 97.291% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 95.269% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 98.173% |
| Unichem Laboratories Limited | 4.86 Billion INR | 73.959% |
| Sequent Scientific Limited | 2.97 Billion INR | 57.469% |
| Novartis India Limited | 1.32 Billion INR | 4.523% |
| Wanbury Limited | 1.73 Billion INR | 26.797% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 69.275% |
| Wockhardt Limited | 16.24 Billion INR | 92.199% |
| Themis Medicare Limited | 1.5 Billion INR | 15.76% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -94.132% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 93.55% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 89.81% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.226% |
| Divi's Laboratories Limited | 32.44 Billion INR | 96.095% |
| NATCO Pharma Limited | 25.73 Billion INR | 95.077% |
| Gufic Biosciences Limited | 4.16 Billion INR | 69.602% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 72.344% |
| Ind-Swift Limited | 2.17 Billion INR | 41.686% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 78.087% |
| FDC Limited | 8.33 Billion INR | 84.8% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -557.348% |
| Granules India Limited | 16.79 Billion INR | 92.459% |
| Medicamen Biotech Limited | 495.49 Million INR | -155.681% |
| Alkem Laboratories Limited | 52.29 Billion INR | 97.578% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 79.641% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -8589.39% |
| Brooks Laboratories Limited | 65.62 Million INR | -1830.642% |
| Megasoft Limited | 342.07 Million INR | -270.358% |
| Strides Pharma Science Limited | 14.38 Billion INR | 91.195% |
| Neuland Laboratories Limited | 8.24 Billion INR | 84.64% |
| Morepen Laboratories Limited | 6.16 Billion INR | 79.438% |
| Hikal Limited | 3.14 Billion INR | 59.693% |
| Indoco Remedies Limited | 6.04 Billion INR | 79.03% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 78.275% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -104.18% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -80.057% |
| Hester Biosciences Limited | 1.27 Billion INR | 0.531% |